企業プロフィール
Exact Sciences 株価・ニュース・カタリスト
- ティッカー:
- EXAS
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for EXAS.
企業概要
事業概要
Exact Sciences is a molecular diagnostics company focused on cancer screening and precision oncology testing. Its most visible franchise is in colorectal cancer screening, but the broader business is built around non-invasive diagnostics and oncology-related testing.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Exact Sciences sits in diagnostics and molecular testing. It is a healthcare innovation company rather than a therapeutic biotech.
ビジネスモデルの特徴
The company earns revenue from diagnostic test adoption, lab workflows, and cancer-screening expansion. Investors watch test volume, reimbursement, product rollout, and the potential for additional oncology diagnostics to broaden the franchise.
バイオ業界での位置付け
Exact Sciences sits near the diagnostics edge of the biotech landscape. It is less binary than a drug developer but still sensitive to adoption trends, reimbursement, and product performance.
今後のカタリスト
- Exact Sciences’ catalysts are Cologuard Plus progress, screening utilization, and any regulatory or commercial update that broadens the early-detection franchise. The next checkpoint matters because it tells investors whether the program is still moving on schedule or whether the timeline needs to be reset. A clean outcome also makes it easier to think about the next regulatory or label step instead of just the current filing.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。